Novartis Sues To Reverse USPTO Judgment
The lawsuit, filed on Friday by California-based Novartis Vaccines and Diagnostics Inc., names the Institut Pasteur and Centre Nationale De La Recherche Scientifique as defendants.
Pursuant to 35 U.S.C. section 146, any party to a USPTO interference can file a civil action seeking review of the USPTO’s decision within 60 days of the...
To view the full article, register now.